Journal of Thoracic Oncology Oncology
Phase III Study of Niraparib Plus Pembrolizumab as Maintenance Therapy for Advanced or Metastatic NSCLC (ZEAL-1L)
The publisher did not provide an abstract — full text is available via the link below.
Journal of Thoracic Oncology Oncology
The publisher did not provide an abstract — full text is available via the link below.